Cargando…
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives
Breast cancer is a multifaceted disease exhibiting both intertumoral and intratumoral heterogeneity as well as variable disease course. Over 2 decades of research has advanced the understanding of the molecular substructure of breast cancer, directing the development of new therapeutic strategies ag...
Autor principal: | Myers, Meagan B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730993/ https://www.ncbi.nlm.nih.gov/pubmed/26858530 http://dx.doi.org/10.2147/PGPM.S56055 |
Ejemplares similares
-
The current and future state of companion diagnostics
por: Agarwal, Amit, et al.
Publicado: (2015) -
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022) -
The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021) -
Multiplexed Prostate Cancer Companion Diagnostic Devices
por: Aidoo-Brown, Josephine, et al.
Publicado: (2021) -
Companion diagnostics: changing patient management
Publicado: (2012)